Empress

Empress Therapeutics

Empress Therapeutics develops oral small-molecule medicines for diverse diseases by using a platform to identify chemical compounds produced by the human body.

Technology-enabled pharmaceutical company

This company develops small molecule drug candidates using artificial intelligence for the pharmaceutical and biotechnology industries.

Empirico

The company develops genetic medicines and target discovery platforms for pharmaceutical partners and patients with common diseases.

AI-enabled drug design

This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.

Drug Discovery

This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.

Iambic

This company develops small molecule medicines for patients with cancer using an artificial intelligence drug discovery platform.

Auron Therapeutics

This company develops small-molecule drugs using an AI-powered platform to treat patients with cancer and inflammatory diseases.

PharmEnable

This company develops small molecule medicines using an artificial intelligence platform for pharmaceutical partners and patients with oncology and neurology conditions.